Compounded semaglutide remains legal under the 503A patient-specific compounding pathway when prepared by licensed compounding pharmacies for individual patients with valid prescriptions, including documented clinical rationale
After this date, the medication may begin to lose its strength or stability, its potency or effectiveness, and in some cases, its chemical composition could begin to change, which means it may not work as intended
Consider the external evidence: External Evidence A massive UK cohort study tracking 57,975 people using GLP-1s within a digital platform found that engaged users those using coaching, logging weight regularly, staying active in the app lost 3.1 percentage points more at 3 months (9.0% vs 5.9%) and 3.5 points more at 5 months (11.5% vs 8.0%) than their non-engaged counterparts
However, Rybelsus is a tablet taken by mouth once a day
However, the compounded versions of semaglutide are not approved by the FDA